Woodward M N, Kenny S E, Vaillant C, Lloyd D A, Edgar D H
Department of Paediatric Surgery, Alder Hey Children's Hospital, University of Liverpool, England.
J Pediatr Surg. 2000 Jan;35(1):25-9. doi: 10.1016/s0022-3468(00)80007-x.
BACKGROUND/PURPOSE: Terminal colonic aganglionosis (Hirschsprung disease) results from incomplete rostrocaudal colonisation of the embryonic gut by neural crest cells (NCC). Mutations in the genes encoding endothelin-3 (EDN3) or its receptor (EDNRB) have been shown to result in a similar aganglionosis. This article describes the development of an organ culture model using embryonic murine gut to determine how endothelin-3 regulates development of the enteric nervous system.
Gut explants from mice of different gestational ages were cultured for up to 3 days in the presence or absence of 5 micromol/L of the specific endothelin-B receptor antagonist BQ788. EDN3 and EDNRB mRNA expression were analysed by reverse-transcription polymerase chain reaction (RT-PCR) and whole-mount in situ hybridisation. NCC were localised using immunoreactivity for PGP 9.5, a specific neuronal marker.
EDN3 mRNA continued to be expressed by caecal mesenchymal cells and EDNRB mRNA by the migrating NCC in culture. Embryonic day (E)11.5 explants were already colonised by NCC up to the terminal ileum. Complete colonisation occurred in organ culture over the next 72 hours (equivalent to E 14.5). Explants of E 12.5 and E 13.5 showed complete colonisation after 48 and 24 hours culture, respectively. Terminal aganglionosis resulted from treatment of E 11.5 and E 12.5 gut explants with 5 micromol/L BQ788, whereas there was no inhibitory effect on E 13.5 explants.
An organ culture model has been developed in which NCC colonisation of embryonic gut mirrors that described in vivo. Blockade of the EDN3/EDNRB receptor pathway shows that the interaction of endothelin-3 with its receptor is only necessary for NCC colonisation at early time-points, despite the continued expression of endothelin-3 mRNA in the gut.
背景/目的:终末结肠神经节细胞缺乏症(先天性巨结肠病)是由于神经嵴细胞(NCC)对胚胎肠道的头尾向结肠定植不完全所致。已证明编码内皮素-3(EDN3)或其受体(EDNRB)的基因突变会导致类似的神经节细胞缺乏症。本文描述了一种使用胚胎小鼠肠道的器官培养模型的建立,以确定内皮素-3如何调节肠神经系统的发育。
将不同胎龄小鼠的肠道外植体在存在或不存在5微摩尔/升特异性内皮素-B受体拮抗剂BQ788的情况下培养长达3天。通过逆转录聚合酶链反应(RT-PCR)和全组织原位杂交分析EDN3和EDNRB mRNA表达。使用针对特定神经元标志物PGP 9.5的免疫反应性对NCC进行定位。
盲肠间充质细胞继续表达EDN3 mRNA,培养中迁移的NCC表达EDNRB mRNA。胚胎第(E)11.5天的外植体在回肠末端已被NCC定植。在接下来的72小时(相当于E 14.5)内,器官培养中发生了完全定植。E 12.5和E 13.5的外植体分别在培养48小时和24小时后显示完全定植。用5微摩尔/升BQ788处理E 11.5和E 12.5肠道外植体导致终末神经节细胞缺乏症,而对E 13.5外植体没有抑制作用。
已建立一种器官培养模型,其中胚胎肠道的NCC定植反映了体内情况。EDN3/EDNRB受体途径的阻断表明,尽管肠道中内皮素-3 mRNA持续表达,但内皮素-3与其受体的相互作用仅在早期时间点对NCC定植是必需的。